CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 105 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $434 | +68.2% | 11,300 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $258 | -10.7% | 11,300 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $289 | -99.9% | 11,300 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $216,000 | +8.0% | 11,300 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $200,000 | +7.5% | 11,300 | 0.0% | 0.00% | – |
Q1 2022 | $186,000 | +14.8% | 11,300 | +9.7% | 0.00% | – |
Q4 2021 | $162,000 | +30.6% | 10,300 | +3.0% | 0.00% | – |
Q3 2021 | $124,000 | -11.4% | 10,000 | 0.0% | 0.00% | – |
Q2 2021 | $140,000 | -13.6% | 10,000 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $162,000 | +1.9% | 10,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $159,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 5 | $0 | 0.00% |